Stryker Corporation
Financials
Valuation Metrics
Stryker Corporation's Market Cap is $117.64B. At end of 2025 it was $134.44B. Ranked #145 of 3,118 in US market (top 5%), #102 of 1,644 on NYSE (top 6%), #9 of 203 in Health Care Equipment & Services (top 4%) by Market Cap.
Investment Metrics(as of 2026-11-02)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $117.64B | US#145/3,118 Sec#9/203 |
| Revenue | $25.84B | US#250/3,118 Sec#16/203 |
| Net Income | $3.73B | US#200/3,118 Sec#11/203 |
| Total Assets | $47.93B | US#337/3,118 Sec#16/203 |
| Net Assets | $23.99B | US#200/3,118 Sec#11/203 |
| Employees | 56,000 | US#231/3,118 Sec#21/203 |
| Value | ||
| P/E | 31.55x | US#1,579/3,118 Sec#58/203 |
| P/B | 4.90x | US#2,165/3,118 Sec#126/203 |
| PEG | 1.14x | US#852/3,118 Sec#41/203 |
| P/S | 4.55x | US#2,168/3,118 Sec#142/203 |
| EV/EBITDA | 20.65x | US#1,892/3,118 Sec#85/203 |
| FCF Yield | 4.00% | US#1,541/3,118 Sec#77/203 |
| Profitability | ||
| ROE | 15.55% | US#853/3,118 Sec#39/203 |
| ROA | 7.78% | US#686/3,118 Sec#40/203 |
| Op. Margin | 22.03% | US#797/3,118 Sec#22/203 |
| Revenue Growth | 8.48% | US#1,397/3,118 Sec#98/203 |
| Earnings Growth | 27.79% | US#723/3,118 Sec#38/203 |
| Financial Health | ||
| Debt Ratio | 99.81% | US#1,096/3,118 Sec#106/203 |
| Total Debt | $14.94B | US#306/3,118 Sec#13/203 |
| FCF | $4.70B | US#169/3,118 Sec#11/203 |
| Cash | $3.39B | US#281/3,118 Sec#15/203 |
| Current Ratio | 2.16x | US#1,126/3,118 Sec#103/203 |
| Net Debt/EBITDA | 1.85x | US#1,280/3,118 Sec#78/203 |
| Dividend | ||
| Div. Yield | 1.12% | US#1,234/3,118 Sec#22/203 |
| Div. Growth | 5.00% | US#811/3,118 Sec#29/203 |
| Performance | ||
| 1Y Return | -13.65% | US#2,425/3,118 Sec#162/203 |
| 1M Return | 11.41% | US#1,154/3,118 Sec#98/203 |
| From 52W High | -21.18% | US#1,735/3,118 Sec#135/203 |
| 1Y MDD | -30.38% | US#1,333/3,118 Sec#67/203 |
| Trading | ||
| Volume | 3,203,656 shares | US#358/3,118 Sec#16/203 |
| Trading Value | $969M | US#59/3,118 Sec#1/203 |
| Per Share | ||
| EPS | $9.73 | US#308/3,118 Sec#20/203 |
| BPS | $62.57 | US#291/3,118 Sec#22/203 |
Company Info
Stryker Corporation operates as a medical technology company in the United States and internationally. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segment offers surgical equipment, patient and caregiver safety technologies, navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, clinical communication and artificial intelligence-assisted virtual care platform technology, and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke and venous thromboembolism; traditional brain and open skull based surgical procedures products; and orthobiologic and biosurgery products, including synthetic bone grafts and vertebral augmentation products. The Orthopaedics segment provides implants for use in total joint replacements, such as hip, knee and shoulder, ankle, and trauma and extremities surgeries; and Mako Shoulder, which expands the smart robotics suite of applications. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 61 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.